Literature DB >> 8663304

Purification and characterization of a soluble form of mammalian adenylyl cyclase.

C W Dessauer1, A G Gilman.   

Abstract

An engineered, soluble form of mammalian adenylyl cyclase has been expressed in Escherichia coli and purified by three chromatographic steps. The enzyme utilizes one molecule of ATP to synthesize one molecule of cyclic AMP and pyrophosphate at a maximal specific activity of 12.8 micromol/min/mg, corresponding to a turnover number of 720 min-1. Although devoid of membrane spans, the enzyme displays all of the regulatory properties that are common to mammalian adenylyl cyclases. It is activated synergistically by Gsalpha and forskolin and is inhibited by adenosine (P-site) analogs with kinetic patterns that are identical to those displayed by the native enzymes. The purified enzyme is also inhibited directly by the G protein betagamma subunit complex. After adenovirus-mediated expression in adenylyl cyclase-deficient HC-1 cells, the enzyme can be stimulated synergistically by Gs-coupled receptors and forskolin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663304     DOI: 10.1074/jbc.271.28.16967

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Regions on adenylyl cyclase that are necessary for inhibition of activity by beta gamma and G(ialpha) subunits of heterotrimeric G proteins.

Authors:  C Wittpoth; K Scholich; Y Yigzaw; T M Stringfield; T B Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Guanylyl cyclases in unicellular organisms.

Authors:  Jürgen U Linder; Joachim E Schultz
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 3.  Molecular details of cAMP generation in mammalian cells: a tale of two systems.

Authors:  Margarita Kamenetsky; Sabine Middelhaufe; Erin M Bank; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

4.  Soluble adenylyl cyclase-dependent microtubule disassembly reveals a novel mechanism of endothelial cell retraction.

Authors:  Nutan Prasain; Mikhail Alexeyev; Ron Balczon; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-24       Impact factor: 5.464

5.  N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer.

Authors:  Rachna Sadana; Nathan Dascal; Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2009-09-25       Impact factor: 4.436

6.  Identification of an intramolecular interaction between small regions in type V adenylyl cyclase that influences stimulation of enzyme activity by Gsalpha.

Authors:  K Scholich; C Wittpoth; A J Barbier; J B Mullenix; T B Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

7.  Characterization and crystallization of a minimal catalytic core domain from mammalian type II adenylyl cyclase.

Authors:  G Zhang; Y Liu; J Qin; B Vo; W J Tang; A E Ruoho; J H Hurley
Journal:  Protein Sci       Date:  1997-04       Impact factor: 6.725

8.  Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state.

Authors:  B Bieger; L O Essen
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

9.  Guanylate cyclase in Dictyostelium discoideum with the topology of mammalian adenylate cyclase.

Authors:  J Roelofs; H Snippe; R G Kleineidam; P J Van Haastert
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

10.  Direct stimulation of adenylyl cyclase 9 by the fungicide imidazole miconazole.

Authors:  James Simpson; Adrienn Pálvölgyi; Ferenc A Antoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.